Initial Training Network for Neurogical disorders orchestrated by cytoKines
Neuroinflammatory disease, in particular multiple sclerosis affects more than 700.000 people within Europe alone. European countries are at the forefront of neuroimmunological research and students in medicine and biology are grea...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
INVASIION
INnoVAtive Solution for Imaging of Infiltrating mONocytes
203K€
Cerrado
TARGETBRAIN
Targeting Brain Inflammation For Improved Functional Recover...
16M€
Cerrado
SAF2013-45178-P
DINAMICA MICROANATOMICA Y MECANISMOS DE FORMACION DE GLIAPSE...
73K€
Cerrado
SAF2009-12869
ACTIVACION DE ASTROCITOS MEDIADA POR FACTORES DE TRANSCRIPCI...
149K€
Cerrado
BFU2017-85832-R
PAPEL DEL MASTOCITO EN LA ACTIVACION MICROGLIAL Y FUNCION SI...
97K€
Cerrado
NEUROTRAFFICKING
Molecular mechanisms controlling leukocyte trafficking in th...
1M€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Neuroinflammatory disease, in particular multiple sclerosis affects more than 700.000 people within Europe alone. European countries are at the forefront of neuroimmunological research and students in medicine and biology are greatly attracted by the field. Neuroimmunology research further impacts our understanding of the ethiopathology of other CNS-disorders including Alzheimer’s Dementia and Morbus Parkinson. The ability of inflammatory immune cells to cause tissue damage within the nervous system is largely governed by soluble mediators including cytokines/chemokines, cytolytic molecules and growth factors. The therapeutic targeting of such mediators has proven successful for the treatment of a number of inflammatory diseases, yet is failing for the treatment of neuroinflammatory disorders. Clearly, the rules and regulatory elements, which govern inflammation and tissue injury within the CNS, differ significantly from those of other tissues and a unique CNS-focused research approach to unravel these rules is required.
In this ITN proposal, we will train ESRs and ERs specifically in Neuroimmunology by combining prominent laboratories in academia and industry on the task to study the communication networks between immune and CNS-resident cells.
Scientifically, we focus particularly on the soluble factors mediating cell-cell communication at the immune-CNS interface. To this end, we combine expertise in molecular and cellular Neuroimmunology with Neuropathology of human and animal models of CNS inflammation. In addition, our goal is to further utilize inflammatory processes for neuroprotection.